- CEO
- Wei Jie Tan
- Sector
- Consumer services
- Industry
- Other consumer services
- Address
- Singapore Singapore
- IPO Date
- Dec 3, 1994
- Business
- AJJ Medtech Holdings Limited is an investment holding company that operates as an integrated medical technology provider and healthcare solutions specialist in the Asia-Pacific region. The company operates through several core business segments, encompassing MedTech Innovations, Medical Device Distribution, Digital Health Solutions, and Healthcare Services. Its primary products and services include the procurement, regulatory management, and distribution of advanced medical devices, surgical instruments, and orthopaedic implants; in-vitro diagnostic equipment, rapid test kits, and point-of-care testing systems; hospital-grade medical consumables, wound care products, and personal protective equipment; artificial intelligence-driven diagnostic software, smart imaging solutions, and clinical workflow automation platforms; telehealth infrastructure, remote patient monitoring tools, and digital clinic management systems; and specialized healthcare services comprising aesthetic medicine, wellness therapies, dermatology, anaesthesiology, and pain management consultancy. AJJ Medtech Holdings Limited serves a diverse client base that includes government and private hospital networks, ambulatory surgical centers, outpatient medical clinics, diagnostic laboratories, healthcare professionals, and individual patients across Singapore, Malaysia, and the broader Southeast Asian market. Founded in 2004 and headquartered in Singapore, the company operates via several operating subsidiaries across medical device distribution and healthcare delivery. In major recent corporate developments, the company executed a strategic restructuring and corporate name change from Livingstone Health Holdings Limited to AJJ Medtech Holdings Limited in February 2024 to signify its expanded focus on medical technology, artificial intelligence healthcare integration, and biomedical supply chain services. Within the last two years, the company has broadened its product portfolio through strategic alliances and distribution partnerships with international medtech innovators and artificial intelligence developers, streamlined its legacy healthcare clinic operations, and completed private share placements to strengthen its balance sheet and fund strategic acquisitions in the regional digital health and medical device sectors.